Send to a Friend Font Size: Increase Decrease

BIIB and ESALF Related Headlines

Jan 25, 2026 11:52PM FDA accepts Eisai's LEQEMBI IQLIK application for priority review
Nov 26, 2025 06:03AM Eisai completes FDA submission for LEQEMBI subcutaneous starting dose
Sep 1, 2025 12:50AM FDA approves weekly subcutaneous injection for LEQEMBI maintenance dosing

BIIB and ESALF Related Press Releases

BIIB and ESALF Related SEC Filings